| Model Number |
CAR-170-C |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hypersensitivity/Allergic reaction (1907); Urticaria (2278)
|
| Date of Event |
07/18/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
A review of the device history record (dhr) was conducted which confirmed that the device met all quality criteria and manufacturing specifications prior to release.There is no information to indicate that a malfunction occurred.Allergic or adverse reactions are known risks of hemodialysis.The nxstage user guide and instructions for use include allergic reaction as a potential risk associated with dialysis therapy and also include warnings to monitor for potential allergic reactions.Biocompatibility of the device has been established.
|
| |
|
Event or Problem Description
|
|
A report was received on (b)(6) 2023 from the caregiver of a 52 year old male patient with a medical history including hypertension and end stage renal disease who stated the patient previously had a hypersensitivity type response during hemodialysis therapy, date not provided.Additional information was received on 06 oct 2023 from the home therapy nurse (htn), who stated the patient experienced generalized urticaria within five minutes of beginning his first in-center hemodialysis treatment on (b)(6) 2023.Per the htn, the patient was treated with 25mg of intravenous diphenhydramine (benadryl) and symptoms resolved.The patient continues to with nxstage therapy and no further hypersensitivity type reactions have been reported.
|
| |
|
Search Alerts/Recalls
|